Internal Medicine, Cardiovascular Disease · McAllen, TX
NPI
1639392665
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1801 S 5th St, Suite 130
McAllen, TX, 78503
Phone (956) 687-7863
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
755 services
Medicare patients, 2024
187
Average age 77
Drug cost, 2024
$1.1M
9,630 prescriptions
Company payments, 2025
$335
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hector Urrutia was code 99213 (office e&m - established), 187 times for 111 patients. In total Hector Urrutia billed 755 services in 36 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 187 | 111 | $57.35 | $11K |
| 99214 Office E&M - Established | Office | 177 | 110 | $86.54 | $15K |
| 93000 Electrocardiogram | Office | 143 | 115 | $9.15 | $1,308 |
| 93306 Echocardiography (TTE/TEE) | Office | 55 | 55 | $144.86 | $7,967 |
| 99204 Office E&M - New | Office | 39 | 39 | $116.85 | $4,557 |
By year: 2022 $89K for 1,306 services; 2023 $62K for 953 services; 2024 $51K for 755 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hector Urrutia prescribed most often to Medicare patients was Metoprolol Succinate, with 1,288 prescriptions and refills. In total Hector Urrutia wrote 9,630 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,288 | 3,528 | 416 | $41K |
| Amlodipine Besylate Generic | 857 | 2,320 | 285 | $5,695 |
| Rosuvastatin Calcium Generic | 779 | 2,190 | 281 | $11K |
| Ramipril Generic | 666 | 1,859 | 243 | $5,945 |
| Fluoxetine Hcl Generic | 499 | 715 | 137 | $1,960 |
| Nifedipine Er Nifedipine | 471 | 1,160 | 148 | $16K |
| Atorvastatin Calcium Generic | 379 | 1,024 | 128 | $3,071 |
| Spironolactone Generic | 319 | 868 | 100 | $5,719 |
| Bisoprolol Fumarate Generic | 284 | 777 | 145 | $13K |
| Paroxetine Hcl Generic | 266 | 525 | 94 | $3,364 |
| Clopidogrel Clopidogrel Bisulfate | 264 | 707 | 99 | $2,798 |
| Xarelto Rivaroxaban | 251 | 535 | 72 | $304K |
| Farxiga Dapagliflozin Propanediol | 238 | 470 | 68 | $246K |
| Ezetimibe Generic | 223 | 649 | 79 | $4,098 |
| Telmisartan-Hydrochlorothiazid Telmisartan/Hydrochlorothiazid | 199 | 481 | 71 | $13K |
Brand drugs: - claims; generic drugs: 8,729 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hector Urrutia $335 ($335 in general payments such as food, travel and fees) from 7 companies. The largest payer was Boston Scientific Corporation with $73.51.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.